QurAlis Corp

SEC filing

Pharmaceuticals · Cambridge, MA

Form D on EDGAR

Amount raised$20Msold at filing

Total offering$24.9M$5M still open

Investors in the raise19count reported to the SEC

FiledSep 5, 2025first sale Aug 21, 2025

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Laia C.D. Crespo-MartinDirector

Shafique C.D. ViraniExecutive Officer

Johannes C.D. FruehaufDirector

Michael C.D. HuttonDirector

Jason C.D. BrownExecutive Officer

Anne C.D. WhitakerDirector

Kasper C.D. RoetDirector, Executive Officer, Promoter

Amy C.D. SchulmanDirector

Luc C.D. DochezDirector

Cillian C.D. KingDirector

Executive officers, directors and promoters as listed on the Form D.